Exact Sciences Corp. shared data from modeling analyses that demonstrate Cologuard, with its included patient navigation system, provides a greater reduction in incidence and mortality from colorectal cancer compared to annual fecal immunochemical test, when it included outreach, with or without a mailed annual FIT, using real world adherence rates in a simulated Medicaid population.
October 25, 2021
· 6 min read
